Mundipharma GmbH

What Mundipharma GmbH does

Mundipharma GmbH is the German operating entity of the global Mundipharma pharmaceutical network, headquartered in Frankfurt, Germany, and founded in 1967. The company is one of several independently associated companies within the Mundipharma International group, which collectively operate across Africa, Asia, Canada, Europe, Latin America, and the Middle East. The German subsidiary operates under Managing Director Dr. Joern Woll (Geschäftsführer), who has articulated a leadership philosophy centered on patient welfare, team development, and collaborative partnerships. Globally, the network is led by CEO Marc Princen and a Global Executive Team.

The business is a pharmaceutical sales, marketing, and distribution operation targeting the German healthcare market. Its core commercial surface is the dedicated professional portal mundipharmapro.com, through which it engages medical professionals (Fachkreise) with product information and HCP-directed services. This indicates a classic enterprise field sales GTM model aimed at prescribers and healthcare providers rather than direct-to-consumer channels. No specific product list, proprietary technology stack, or AI/ML capabilities were disclosed in the source data.

Mundipharma GmbH generates revenue through pharmaceutical product sales to healthcare providers and patients, consistent with regulated pharmaceutical pricing frameworks. Pricing details are not publicly disclosed. The company maintains 101-250 employees in Germany and is part of a broader corporate network whose German operations are the subject of this profile. Corporate ownership flows through Mundipharma International, and no detailed equity structure, investor base, or financial disclosures are available in the supplied material.

Name

Mundipharma GmbH

Legal name

Mundipharma

Website

https://mundipharma.de

Company type

Private

Founded year

1967

Operating status

Operating

Headcount range

101–250 employees

Short description

Mundipharma GmbH is the German subsidiary of the global Mundipharma International pharmaceutical network, marketing and distributing pharmaceutical products to healthcare professionals and patients in Germany through field sales and a dedicated HCP portal.

Ownership category

akta.pro rank

Product category

Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)

akta.pro secondary industry

Specialty Pharmaceutical Distributors (HLAIAJAB)

Keywords

• Pharmaceutical manufacturing
• Prescription drugs
• Healthcare products
• Pharmaceutical distribution
• Medical professional services

Headquarters

HQ city

Frankfurt

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

1. Pharmaceutical Product Sales: Mundipharma operates as a global pharmaceutical company generating revenue through the sale of pharmaceutical products and medicines to healthcare providers and patients across their global network.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Mundipharma GmbH researches, develops, manufactures and markets pharmaceutical drugs and health products as part of the global Mundipharma International network. The German entity serves healthcare professionals (Fachkreise) through a dedicated professional portal (mundipharmapro.com) that provides product information and services to the medical community.

Product overview

Mundipharma is a globally operating pharmaceutical company focused on patient care. The company operates under the leadership of global CEO Marc Princen and maintains presence across Africa, Asia, Canada, Europe, Latin America, and the Middle East. The German subsidiary (Mundipharma GmbH) provides access to a Fachkreise (medical professionals) portal at mundipharmapro.com for healthcare professionals.

Differentiator

Problem solved

Functional benefit

Brands

• Mundipharma Pro: Professional portal for healthcare professionals (Fachkreise) at mundipharmapro.com

Products and services

• Mundipharma Pro (Fachkreise Portal) Dedicated professional portal at mundipharmapro.com that serves healthcare professionals (Fachkreise) such as physicians and pharmacists with pharmaceutical product information and services for the German market.

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Mundipharma InternationalcoreOthersMundipharma GmbH is part of the Mundipharma International network of independently associated pharmaceutical companies operating across Africa, Asia, Canada, Europe, Latin America and the Middle East under the leadership of global CEO Marc Princen.

Scale indicators1 record

Recent moves4 records

Expansion highlights4 records

Regional players

• Aspen Pharmacare: South African-headquartered global specialty and branded generics pharmaceutical company. Comparable for its emerging-markets-focused go-to-market across Africa, Asia and Latin America, though headquartered outside Europe.

Direct peers

• Teva Pharmaceutical Industries: Israeli-headquartered global pharmaceutical company with leadership in generics and a growing specialty portfolio. Comparable as a globally distributed pharma operator selling into both mature and emerging markets.
• STADA Arzneimittel: German-headquartered pharmaceutical company specializing in generics and specialty pharma with strong presence across Europe and emerging markets. Comparable as a Germany-based pharma company with a similar geographic footprint strategy.
• Viatris: Global pharmaceutical company formed from the combination of Mylan and Upjohn, with a broad branded, generic and specialty portfolio across more than 165 countries. Comparable in business model mix and global distribution.
• Grünenthal: Germany-based, privately-held pharmaceutical company focused on pain and specialty therapeutics. Closely comparable as an independent, mid-sized German pharma company with branded specialty products and international distribution.

Broad incumbents

• Pfizer: One of the world's largest biopharmaceutical companies with a broad branded and specialty portfolio. Comparable as a global pharma competitor across many of the same therapeutic categories and geographies.
• Bayer AG: German-headquartered global pharmaceutical and life sciences company. Comparable as a large, diversified pharma operator selling branded drugs internationally, but with significantly broader consumer health and crop science portfolios.
• Boehringer Ingelheim: Independent, privately-held German pharmaceutical company with global operations. Highly comparable given the independent, family-controlled structure and research-driven pharma model, though larger in scale and respiratory/cardiology focus.
• Merck KGaA: German-headquartered science and technology company with a substantial pharmaceuticals segment. Comparable as a Germany-based diversified pharma player serving global markets including emerging regions.
• GSK: UK-headquartered global biopharma company with a diversified specialty medicines and vaccines portfolio. Comparable as a multinational branded pharma operator selling into European, emerging and developed markets.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/mundipharma-deutschland

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mundipharma GmbH